Table 6.
Silk fibroin hydrogel for the encapsulation of therapeutic cells.
| Hydrogel delivery system | Cell type | Application | Outcome | Reference |
|---|---|---|---|---|
| SF hydrogel | BMSCs | Bone regeneration | Prolonged survival of BMSCs | [167] |
| SF/pullan composite hydrogel | MSCs | Cell delivery | Improved cell survival | [170] |
| SF hydrogel | Muscle-derived MSCs | Angiogenesis Muscle regeneration | Enhanced tissue regeneration | [174] |
| SF-Alginate | MSCs Neural progenitor cells |
Tissue engineering | Enhanced cell survival | [194] |
| SF-DMPG | L929 NIH/323 SaOS-2 CaSki |
Tissue engineering | Biocompatible Cytoprotective |
[175] |
| SF-DMPG | SaOS-2 | Bone tissue engineering | Osteogenic differentiation | [173] |
| SF-chitosan | Hepatocytes | Tissue engineering | Enhanced functional phenotype | [172] |
| SF microgel | L929 Myoblast cells |
Tissue engineering | VEGF release | [51] |